STIs in the Time of Covid-19
Increasing public awareness of the laboratory’s role in public health offers an opportunity to slow the spread of sexually transmitted infections.
Increasing public awareness of the laboratory’s role in public health offers an opportunity to slow the spread of sexually transmitted infections.
The moderate-complexity assay is designed to detect varicella-zoster virus DNA from cutaneous and mucocutaneous swab specimens.
The Aptima Combo 2 and Xpert CT/NG are the first assays cleared to perform extragenital diagnostic testing for chlamydia and gonorrhea via specimens from the throat and rectum.
With syphilis rates on the rise, a reverse screening algorithm offers high clinical value.
Read MoreThe kit contains synthetic DNA to simulate Mycoplasma genitalium, as well as five mutations known to confer resistance to macrolide antibiotics.
Read MoreTo find out more about Quest’s new survey on sexually transmitted infections, CLP recently spoke with Damian P. Alagia III, MD, FACOG, FACS, medical director for women’s health at Quest Diagnostics.
Read MoreThe acquisition of FTD increases the menu of the Siemens Healthineers Versant kinetic polymerase chain reaction molecular system by more than 80 assays and syndromic panels.
Read MoreThe company will use its US base to support current clinical trial activity for ResistancePlus MG in preparation for an expected 2018 launch.
Read MoreValidated for use on multiple lesion specimen types, the test is designed to streamline workflows and support rapid, appropriate clinical management of infections with similar symptoms.
Read MoreThe Atomo HIV Self Test has been granted a CE mark by a European Union notified body.
Read MoreThe New Jersey Health Foundation has awarded an innovation grant to develop a nanotechnology-enhanced biochip to help detect deadly diseases.
Read MoreA comprehensive literature review finds that the Biodesix VeriStrat test can aid in more precise treatment prognosis to inform treatment choice for patients with non-small cell lung cancer.
Read MoreMologic Ltd has received the CE mark for BVPro, a rapid point-of-care test for patients presenting with symptoms of vaginosis.
Read MoreWith connectivity, point-of-care testing is on the front line when it comes to diagnosing and managing chronic diseases.
Read MoreBSRI has announced a collaboration with Hologic to measure the human immunodeficiency virus latent reservoir more precisely and efficiently in clinical samples using the Panther system.
Read MoreAt the 2017 annual meeting of the American Association for Clinical Chemistry, Ortho Clinical Diagnostics will present 10 scientific posters highlighting its focus on immunodiagnostics, with discussions on acute kidney injury (AKI), insulin, and infectious disease.
Read MoreHologic has obtained FDA clearance to market its Aptima herpes simplex virus 1 and 2 molecular assay on the fully automated Panther system.
Read MoreThis month’s issue features molecular diagnostics technologies from such companies as Hologic and Thermo Fisher Scientific.
Read More